Amesite Inc. (AMST) stock
AMSTNasdaqServices-Prepackaged SoftwareFiscal year ends June 30
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 10/3028% below fair value
$0.47−0.00 (-0.77%)
Close on Nov 13, 2026Market cap $3.11MP/E –Yield –
Amesite EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
Amesite's EPS for the twelve months ending Sep 30, 2026 was -$0.60. For fiscal 2026 it was -$0.63. The highest annual figure on record is -$0.63 in fiscal 2026.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | -$0.63 | – |
| FY2025 | Jun 30, 2025 | -$1.03 | – |
| FY2024 | Jun 30, 2024 | -$1.73 | – |
| FY2023 | Jun 30, 2023 | -$1.68 | – |
| FY2022 | Jun 30, 2022 | -$4.67 | – |
| FY2021 | Jun 30, 2021 | -$7.08 | – |
Quarterly eps
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ3 2026 | Sep 30, 2026 | -$0.12 | – |
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | -$0.17 | – |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | -$0.15 | – |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | -$0.16 | – |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | -$0.14 | – |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | -$0.20 | – |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | -$0.16 | – |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | -$0.40 | – |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | -$0.34 | – |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | -$0.46 | – |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | -$0.56 | – |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | -$0.36 | – |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | -$0.35 | – |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | -$0.37 | – |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | -$0.37 | – |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | -$0.28 | – |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | -$0.69 | – |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | -$0.93 | – |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | -$1.12 | – |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | -$1.32 | – |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | -$1.32 | – |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | -$1.10 | – |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | -$1.36 | – |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | -$1.34 | – |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | -$3.69 | – |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | -$0.95 | – |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | -$0.66 | – |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | -$0.78 | – |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | -$0.84 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?